α-fetoprotein levels after interferon therapy and risk of hepatocarcinogenesis in chronic hepatitis C-Reference-Cited by-同舟云学术

α-fetoprotein levels after interferon therapy and risk of hepatocarcinogenesis in chronic hepatitis C

Published:2013-08-19 Issue:4 Volume:58 Page:1253-1262
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Asahina Yasuhiro,Tsuchiya Kaoru¹,Nishimura Takashi,Muraoka Masaru,Suzuki Yuichiro,Tamaki Nobuharu¹,Yasui Yutaka¹,Hosokawa Takanori¹,Ueda Ken¹,Nakanishi Hiroyuki¹,Itakura Jun¹,Takahashi Yuka¹,Kurosaki Masayuki¹,Enomoto Nobuyuki²,Nakagawa Mina³,Kakinuma Sei,Watanabe Mamoru³,Izumi Namiki¹

Affiliation:

1. Department of Gastroenterology and Hepatology; Musashino Red Cross Hospital; Tokyo; Japan

2. First Department of Internal Medicine; Faculty of Medicine, University of Yamanashi; Yamanashi; Japan

3. Department of Gastroenterology and Hepatology; Tokyo Medical and Dental University; Tokyo; Japan

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.26442/fullpdf

Reference41 articles.

1. Hepatitis C and hepatocellular carcinoma;Bisceglie;Semin Liver Dis,1995

2. Hepatocellular carcinoma;Llovet;Lancet,2003

3. Global cancer statistics in the year 2000;Parkin;Lancet Oncol,2001

4. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus;Kiyosawa;Hepatology,1990

5. Effect of aging on risk for hepatocellular carcinoma in chronic hepatitis C virus infection;Asahina;Hepatology,2010

Cited by 227 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EASL position paper on clinical follow-up after HCV cure;Journal of Hepatology;2024-08

2. High serum gamma‐glutamyltransferase level after hepatitis C virus elimination is a risk factor for the development of hepatocellular carcinoma;Hepatology Research;2024-07-29

3. Unmet needs in the post-direct-acting antivirals era: The risk and molecular mechanisms of hepatocellular carcinoma after hepatitis C virus eradication;Clinical and Molecular Hepatology;2024-07-01

4. Fibrosis-4 index stratifies risks of hepatocellular carcinoma in patients with chronic hepatitis C;Journal of the Formosan Medical Association;2024-06

5. Clinical practice guidelines for molecular tumor marker, 2nd edition review part 2;International Journal of Clinical Oncology;2024-03-17